We recently published a list of 13 Best Cheap Dividend Stocks To Buy Right Now. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other best cheap dividend stocks to buy right now.

Shrewd investors know that bear markets open up great opportunities to pick up shares of excellent companies from the discount bin. It's no secret why Pfizer has not performed well recently. The company was never going to keep up those sales year in and year out.

The market sentiment in the next few months is likely to be quite positive for Pfizer. Read why I maintain my strong buy rating on PFE stock.

There is no better period, given the volatility in the markets today, to rotate assets into dividend stocks, said Steven Cress, VP of Quantitative Strategy at Seeking Alpha. During Seeking Alpha’s Dividend Investing Forum virtual event,

Pfizer (PFE) announced that James List has joined the company as Chief Internal Medicine Officer. List will oversee Pfizer’s Internal Medicine

In a report released today, Kerry Holford from Berenberg Bank maintained a Hold rating on Pfizer (PFE – Research Report), with a price target

The pharmaceutical industry is evolving continuously with the advancements in drug discovery with Artificial Intelligence (AI), propelling the industry’s growth. Amid this backdrop, quality medical stocks Pfizer (PFE),

NEW YORK, February 24, 2025--Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer ...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility

Uniondale-based McHugh Furnishings, a provider of specialty furnishings for education, healthcare, entertainment and multifamily housing, has expanded with the acquisition of an upstate furniture company.

Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy ...